Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
Primary Objective: * To compare the tumour response rate of combination chemotherapy irinotecan/cisplatin (IC) versus docetaxel/cisplatin (DC) in advanced NSCLC patients who responded to 3 courses of docetaxel/cisplatin. Secondary Objectives : * To compare the time to progression after chemotherapy treatment between the IC and DC arms of treatment. * To compare the toxicity profile of the IC and DC arms of treatment.
Epistemonikos ID: 4c8eab57e259b4b16f75873b8bd9597cfa0bce46
First added on: May 04, 2024